{
  "actions": [
    {
      "acted_at": "2025-02-24",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2025-02-24",
      "action_code": "",
      "committees": [
        "SSFI"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Finance.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s694-119",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "Referred To"
      ],
      "committee": "Senate Finance",
      "committee_id": "SSFI"
    }
  ],
  "congress": "119",
  "cosponsors": [
    {
      "bioguide_id": "B001305",
      "district": null,
      "name": "Budd, Ted",
      "original_cosponsor": false,
      "sponsored_at": "2025-04-08",
      "state": "NC",
      "title": "Sen.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "K000377",
      "district": null,
      "name": "Kelly, Mark",
      "original_cosponsor": true,
      "sponsored_at": "2025-02-24",
      "state": "AZ",
      "title": "Sen.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "P000145",
      "district": null,
      "name": "Padilla, Alex",
      "original_cosponsor": false,
      "sponsored_at": "2025-04-08",
      "state": "CA",
      "title": "Sen.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2025-02-24",
  "number": "694",
  "official_title": "A bill to amend title XVIII of the Social Security Act to provide a phase-in for plasma-derived products under the manufacturer discount program.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "hr1476-119",
      "identified_by": "CRS",
      "reason": "identical",
      "type": "bill"
    }
  ],
  "short_title": "PLASMA Act",
  "sponsor": {
    "bioguide_id": "T000476",
    "district": null,
    "name": "Tillis, Thomas",
    "state": "NC",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2025-02-24",
  "subjects": [
    "Blood and blood diseases",
    "Drug therapy",
    "Health",
    "Health care costs and insurance",
    "Manufacturing",
    "Medicare",
    "Prescription drugs"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2025-02-24",
    "date": "2025-08-18T19:08:45Z",
    "text": "Preserving Life-saving Access to Specialty Medicines in America Act or the PLASMA Act\n\nThis bill phases-in certain price adjustments for plasma-derived products under the Medicare prescription drug benefit's Manufacturer Discount Program.\n\nCurrent law requires manufacturers of covered drugs under the Medicare prescription drug benefit to provide a 10% discount for covered drugs during the initial coverage phase (i.e., before a beneficiary reaches the out-of-pocket spending threshold) and a 20% discount during the catastrophic coverage phase (i.e., after a beneficiary reaches the out-of-pocket spending threshold).\u00a0\n\nThe bill phases-in discounts for plasma-derived products over several years, starting with a 1% discount in 2026 for both the initial and catastrophic coverage phases, and ending with a 10% discount beginning in 2030 for the initial coverage phase and a 20% discount beginning in 2032 for the catastrophic coverage phase."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "PLASMA Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "PLASMA Act",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Preserving Life-saving Access to Specialty Medicines in America Act",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to amend title XVIII of the Social Security Act to provide a phase-in for plasma-derived products under the manufacturer discount program.",
      "type": "official"
    }
  ],
  "updated_at": "2025-11-19T03:06:44Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/119/s/BILLSTATUS-119s694.xml"
}